July 29, 2016 8:19 PM ET

Pharmaceuticals

Company Overview of Eu Yan Sang International Ltd

Company Overview

Eu Yan Sang International Ltd, an investment holding company, manufactures, processes, distributes, retails, and sells traditional Chinese and other medicines under the Eu Yan Sang brand name. It operates through four segments: Traditional Chinese Medicine (TCM), Non-Traditional Chinese Medicine, Clinics, and Others. The company offers Chinese herbs and other medicinal products, which range from Chinese herbs and Chinese proprietary medicines to health foods and supplements. It is also involved in the property investment activities; development, manufacture, and distribution of spa products; and development of iGates, an advanced technology to decipher chemical components in traditional Chin...

Eu Yan Sang Centre

21 Tai Seng Drive

Singapore,  535223

Singapore

Founded in 1879

Phone:

65 6225 3211

Fax:

65 6225 8276

Key Executives for Eu Yan Sang International Ltd

Eu Yan Sang International Ltd does not have any Key Executives recorded.

Eu Yan Sang International Ltd Key Developments

Eu Yan Sang International Ltd Appoints TEO Boon Leong Daniel as Chief Operating Officer

Eu Yan Sang International Ltd. announced the appointment of TEO Boon Leong Daniel as Chief Operating Officer.

Eu Yan Sang International Ltd, Special/Extraordinary Shareholders Meeting, Jun 15, 2016

Eu Yan Sang International Ltd, Special/Extraordinary Shareholders Meeting, Jun 15, 2016, at 10:00 Singapore Standard Time. Location: DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3 Level 41, T&M Conference Room Singapore 018982 Singapore Agenda: To approve to amend the conditions of the SGD 25,000,000, 4.50 % fixed rate Notes due 2016 of Eu Yan Sang International Ltd. ("EYS") by inserting a new Condition 5.5 immediately after Condition 5.4; to consider subject to the exercise by the company of the option to redeem the Notes in the new Condition 5.5, the Noteholders waive the occurrence of the non-compliance with Clauses 12.1(k); and to consider subject to the exercise by the Company of the option to redeem the Notes in the new Condition 5.5, the Noteholders waive the occurrence of the Potential Event(s) of Default or (as the case may be) Event(s) of Default under Conditions 11(b) and 11(q) of the Notes, in each case, which may or will occur as a result of the Transactions.

Eu Yan Sang International Ltd Announces Interim Tax Exempt One-Tier Dividend for the Fiscal Year 2016, Payable on 16 June 2016

Eu Yan Sang International Ltd. announced interim tax exempt one-tier dividend of 2.5 cents per ordinary share for the fiscal year 2016, payable on 16 June 2016. The dividend will be paid to shareholders registered in the Register of Members as at the books closure date of 25 May 2016.

Similar Private Companies By Industry

Company Name Region
A2 Bioscience Pte Ltd. Asia
Blue Sphere Singapore Pte. Ltd. Asia
Dialic Pte. Ltd. Asia
Excrx Singapore Pte. Ltd. Asia
Healthy Glow Pte. Ltd. Asia

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
May 16, 2016
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Eu Yan Sang International Ltd, please visit www.euyansang.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.